WebMechanism of Action 12.2 . Pharmacodynamics 12.3 . Pharmacokinetics . 13 NONCLINICAL TOXICOLOGY . 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility . 14 CLINICAL STUDIES 16 HOW SUPPLIED/STORAGE AND HANDLING 17 PATIENT COUNSELING INFORMATION *Sections or subsections omitted from the full prescribing … WebOdevixibat, sold under the trade name Bylvay, is a medication for the treatment of progressive familial intrahepatic cholestasis (PFIC). It is taken by mouth. Odevixibat serves as a non-surgical option to help patients with PFIC by disturbing the enterohepatic circulation. ... Mechanism of action
Bylvay (odevixibat) dosing, indications, interactions, adverse effects ...
Odevixibat, sold under the trade name Bylvay, is a medication for the treatment of progressive familial intrahepatic cholestasis (PFIC). It is taken by mouth. Odevixibat is a reversible, potent, selective inhibitor of the ileal bile acid transporter (IBAT). The most common side effects include diarrhea, abdominal pain, hemorrhagic diarrhea, … WebMechanism of Action. Inhibitor of the ileal bile acid transporter (IBAT) IBAT inhibitors act locally in the distal ileum to decrease reuptake of bile acids and increase clearance of … state of nc department of justice
Scientific Focus - Albireo Pharma
WebMar 6, 2024 · Mechanism of Action Sodium-bile acid cotransporter inhibitors Orphan Drug Status Yes - Primary biliary cirrhosis; Biliary atresia; Intrahepatic cholestasis; Alagille … WebOct 5, 2024 · Bylvay was more effective than a placebo (dummy treatment) at reducing the severity of PFIC in one main study, which involved 62 patients aged between 6 months and 18 years. ... Suspected side effects reported with Bylvay are carefully evaluated and any necessary action taken to protect patients. Other information about Bylvay . Bylvay … WebBylvay may impair absorption of fat-soluble vitamins (FSV), which include vitamins A, D, E and K (vitamin K is assessed by measuring INR). The patient’s health care provider will … state of nc eye insurance